))
Episode 21. Newly Diagnosed Mantle Cell Lymphoma
Manage episode 362351566 series 3369804
Rajshekhar Chakraborty and Ashwin Kishtagari, Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Rajshekhar Chakraborty and Ashwin Kishtagari, Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
In this episode, we delve into the management of newly diagnosed mantle cell lymphoma with Dr. Martin Dreyling. Here the shownotes:
2:11 How to diagnose mantle cell lymphoma (MCL)?
6:51 Clinical manifestations of mantle cell lymphoma
7:52 How to manage leukemic variant of MCL?
12:08 Is Watch-and-Wait reasonable in selected cases of nodal MCL with low Ki-67?
17:21 Overview on treatment of newly diagnosed MCL
19:03 Are all cytarabine-based regimens for MCL created equally?
RCT of Autologous Transplantation in MCL: https://pubmed.ncbi.nlm.nih.gov/15591112/
21:39 In a world without upfront ibrutinib access as per TRIANGLE trial, do all fit patients with MCL need consolidation with auto-transplant?
22:44 How to approach unfit patients with newly diagnosed MCL?
RCT of bortezomib-based therapy (VR-CAP) in newly diagnosed MCL: https://pubmed.ncbi.nlm.nih.gov/25738670/
24:57 SHINE Trial-RCT of Ibrutinib plus BR in newly diagnosed MCL: https://pubmed.ncbi.nlm.nih.gov/35657079/
30:38 TRIANGLE Trial-RCT of upfront ibrutinib with or without auto-transplant in newly diagnosed MCL:
https://ashpublications.org/blood/article/134/Supplement_1/2816/423504
43:01: Does Allo-Transplant have any role in MCL?
44:08: What are the likely next breakthroughs in newly diagnosed MCL space?
48 에피소드
공유
